Diskussionsleitung: G. Klein (Hannover), J. W. Schrickel (Bonn)
(P1998) | Atrial tissue slices: a model to study mechanically-induced fibrosis | |
T. Schiatti, J. Greiner, E. Rog-Zielinska, T. Seidel, P. Kohl, U. Ravens, R. Peyronnet (Freiburg im Breisgau, Erlangen) | ||
(P1999) | Antiarrhythmic potential of SGLT2 inhibitors – Dapagliflozin suppresses action potential formation in atrial cardiomyocytes | |
A. Paasche, F. Wiedmann, M. Kraft, N. Jávorszky, P. L. Blochberger, B. Yesilgöz, M. Karck, N. Frey, C. Schmidt (Heidelberg) | ||
(P2000) | Reversibility of atrial fibrillation-associated electrical and structural remodelling on a clinical and cellular level | |
A. Paasche, F. Wiedmann, B. Yesilgöz, M. Kraft, P. L. Blochberger, N. Frey, C. Schmidt (Heidelberg) | ||
(P2001) | Ketodoxapram – a promising new option in the treatment of atrial fibrillation | |
M. Kraft, F. Wiedmann, K. I. Foerster, A. Paasche, B. Yesilgöz, P. L. Blochberger, Y. L'hoste, R. Arif, G. Warnecke, M. Karck, N. Frey, J. Burhenne, W. E. Haefeli, C. Schmidt (Heidelberg) | ||
(P2002) | Optoacoustic Imaging of Cardiac Electrophysiology Using Genetically Encoded Voltage Indicators | |
P. S. Kaas, F. Schneider-Warme, C. Zgierski-Johnston (Freiburg im Breisgau) | ||
(P2003) | High performance automated patch-clamp characterisation of mammalian atrial cardiomyocytes. | |
F. Seibertz, M. Rapedius, F. E. Fakuade, P. Tomsits, L. Cyganek, N. Becker, S. Clauß, N. Fertig, N. Voigt (Göttingen, Munich, München) | ||
(P2004) | Optogenetic improvements on the way to an atrial fibrillation model in vitro | |
K.-F. Müller, B. Pan, J. Krause, T. Stüdemann, I. Braren, F. Weinberger, A. Hansen, T. Christ, T. Eschenhagen, J. Stenzig (Hamburg) | ||
(P2005) | Linksatriales metabolisches und interstitielles Remodelling bei chronischer Niereninsuffizienz --- Rolle von sympathoadrenerger Aktivität und RAGE | |
M. Mauz, S.-R. Selejan, M. Hohl, P. Markwirth, J. Blaumer, S. Bettink, T. Speer, A. Kazakov, J. Wintrich, F. Mahfoud, M. Böhm (Homburg/Saar, Homburg) |